Association between CYP2C9 polymorphism and warfarn dose (CROSBI ID 530776)
Prilog sa skupa u zborniku | sažetak izlaganja sa skupa
Podaci o odgovornosti
Samardžija, Marina ; Topić, Elizabeta ; Štefanović, Mario ; Zibar, Lada ; Samardžija, Goran ; Balen, Sanja ; Včev, Aleksandar ; Domanović, Dragoslav ; Barbić, Jerko ; Petrak, Daniel ; Šišljagić, Vladimir
engleski
Association between CYP2C9 polymorphism and warfarn dose
In vitro studies show association between alleles CYP2C9*2, *3 and significantly reduced metabolism of various CYP2C9 substartes in comparison with the wild type. The aim of the study was to determine kind and significante of the association between CYP2C9 polymorphism and warfarin anticoagulant daily therapy dose.
CYP2C9; Polymorphism; Warfarin dose; In vitro; Alleles; Wild type; Anticoagulant dose
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
S69-x.
2007.
nije evidentirano
objavljeno
Podaci o matičnoj publikaciji
Budimpešta:
Podaci o skupu
Congress of the European & African Division
poster
29.08.2007-02.09.2007
Budimpešta, Mađarska